BAE Systems share price: fresh buyback filing hits tape before London open
21 January 2026
1 min read

BAE Systems share price: fresh buyback filing hits tape before London open

London, Jan 21, 2026, 07:48 GMT — Premarket

BAE Systems revealed on Wednesday that it repurchased 103,099 shares on Tuesday as part of its ongoing buyback programme, with plans to cancel them. The defence giant paid between 2,047 pence and 2,079 pence per share, according to a regulatory filing. The volume-weighted average price came in at 2,065.30 pence. So far, the company has repurchased 15.22 million shares in this tranche, which kicked off last July. 1

BAE stock is trying to regain ground after slipping in the previous session, just as the company announces a buyback update amid a busy news day. Shares ended Tuesday at 2,066 pence, off 20 pence or 0.96%, sitting slightly below the price range where recent repurchases took place. 2

The company’s steady buying stands out amid shaky risk appetite. The FTSE 100 dropped 0.72% on Tuesday after U.S. President Donald Trump threatened tariffs connected to Greenland. “Geopolitical tensions have dented sentiment,” said Laura Cooper, senior macro strategist at Nuveen. 3

A separate filing on Tuesday revealed BAE bought 101,668 shares on Monday at a volume-weighted average price of 2,104.69 pence, with the highest purchase price hitting 2,135 pence. Morgan Stanley handled the trades, the company said, and the shares will be cancelled. 4

BAE’s shares oscillated between 2,043 pence and 2,081 pence on Tuesday, within a narrow yet active range. Trading volume hit roughly 23.5 million shares, per historical pricing data. The stock had closed at 2,086 pence on Monday, ahead of Tuesday’s retreat. 5

Looking further out, BAE remains near its peak. Its year-to-date high hit 2,159 pence, pushing the company’s market cap to roughly £60.3 billion, according to Hargreaves Lansdown data. 6

Investors are keeping a close eye on how the political debate over defence spending and contractor profits unfolds, especially in the U.S. Reuters reported Tuesday that peer QinetiQ is reshaping its U.S. operations to align with the administration’s agenda after Trump pushed for major reforms, including barring U.S. contractors from paying dividends or buying back shares. 7

For BAE, the immediate issue is if steady buyback demand can steady price dips or if broader market moves will overshadow it on any given day. Their repurchase sizes are minor compared to daily volumes, yet their consistency can make a difference when liquidity dries up near the open.

The downside scenario is straightforward. If tariff threats turn into reality and the market remains risk-averse, defence stocks could drop alongside other sectors, despite solid order books. Buyback programs might also slow down or pause if cash priorities shift or regulators take a tougher stance.

BAE Systems is set to release preliminary results for the year ending Dec. 31, 2025, on Feb. 18. Investors will be watching closely for updates on guidance, cash flow, and the speed of share buybacks. 8

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Davos 2026: PwC CEO survey flags 5-year low in revenue confidence as India jumps to No.2 investment pick
Previous Story

Davos 2026: PwC CEO survey flags 5-year low in revenue confidence as India jumps to No.2 investment pick

Anglo American shares jump early as metals rally and tariff fears jolt markets
Next Story

Anglo American shares jump early as metals rally and tariff fears jolt markets

Go toTop